CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Driving the Future of Drug Development by Coupling Single Cell Sequencing and AI

Life Sciences Review | Monday, July 13, 2020
Tweet

Coupling the single-cell sequencing with statistical machine learning and AI tools paves the way for a new era to develop efficacious therapeutics.


FREMONT, CA: Single-cell sequencing has significantly transformed the study of biological tissues and systems at the cellular and molecular level. The latest advances in the technology have enabled the interrogation of distinct subsets of cell populations within tissues and connected molecular markers that may function as imperative disease drivers. Combining single-cell omics with other omics technologies and machine learning tools like artificial intelligence (AI) can offer key insights about cellular and molecular targets that drive diseases. Characterization of disease pathways and systems can help lead to more effective disease treatment strategies like cell-based and immunotherapies. Read on to know more. 


Significant strides have been made in the innovation of single-cell technology and its use across different biological research areas. Single-cell RNA sequencing has contributed the most to understanding a single cell's functional biology in broader populations of cells, assisting in highlighting the presence of different cell populations within tissues and their distinct roles in disease. 


Evaluating tissues at a single cell level makes it possible to capture different cell types and cell states within a sample, allowing for the interrogation of heterogeneity within a bulk cell population and identifying rare cell types.


AI-based tools give rise to personalized treatments. Going from static snapshots to full dynamics enables researchers to move from descriptive towards predictive models. This might help to understand disease progression or to unravel cell signaling in response to treatment. In the end, it is all about the samples, and the added sample improves signature scores, enabling for more accurate cell type classification, which is looped into the database and restarts the cycle. This will also allow building an in-house human cell atlas of disease, which allows comparison of healthy cells and diseased with the identification of unique cell types and the potential drivers for them.


In conclusion, combining these detailed approaches can widen the understanding of human disease biology at the cellular and molecular level to find functional targets that can navigate therapeutic drug development.


 


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/driving-the-future-of-drug-development-by-coupling-single-cell-sequencing-and-ai-nwid-88.html